CPAP APAP denied as duplicate or overlapping therapy by UnitedHealthcare?
If two medications appear duplicative on paper but serve different clinical purposes (e.g., short-acting vs long-acting), the appeal needs to spell out the clinical rationale for both.
US health-plan appeal rights
Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules
Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.
What UnitedHealthcare typically requires
UnitedHealthcare's specific coverage criteria for cpap apap are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.
The UnitedHealthcare angle on CPAP APAP
## Why UnitedHealthcare Denied Your CPAP/APAP as "Duplicate Therapy" — and How to Appeal
A duplicate-therapy denial for CPAP or APAP means UHC's system flagged that you already have an active authorization or claim for a device that serves the same function. This most commonly happens in three situations: (1) a prior CPAP is still within UHC's covered useful-life window and a replacement is being requested; (2) you are covered under two insurance plans (coordination of benefits) and UHC sees the other insurer's claim; or (3) a billing or coding error created a phantom duplicate in UHC's system.
## Why This Denial Is Appealable
If the "duplicate" device is broken, lost, clinically inadequate, or if you have had a documented change in clinical status requiring a different device configuration (e.g., CPAP to APAP following a pressure titration), the duplicate designation is incorrect on its face. Denials based on administrative coding errors are routinely overturned when the facts are clearly laid out.
## Federal Appeal Framework
- ERISA §503: Full-and-fair internal review; the reviewer must have relevant clinical expertise and must not have been involved in the original denial.
- ACA §2719 / External Review: Within approximately four months of your final internal denial, you may request an Independent Review Organization (IRO) review. Confirm the exact deadline on your denial letter.
- Expedited review: Available if clinical urgency is documented — for example, your current device is non-functional and continued OSA is causing a health risk.
## Concrete Appeal Steps and Timeline
1. Call UHC's DME department and ask exactly which claim or authorization they consider to be the "duplicate" — get a reference number and date. 2. Obtain UHC's current CPAP/APAP coverage and replacement policy from uhcprovider.com or by request. 3. Prepare documentation showing either that no functional equivalent device is currently active, or that clinical circumstances justify a second device. 4. File the Level 1 internal appeal within the deadline on the denial notice (commonly 180 days). 5. If denied, proceed to external review within four months.
## Documentation to Gather
- Device history: Records of prior device(s) obtained, including dates and DME supplier information — showing the equipment is beyond its useful life or is no longer functioning.
- Malfunction or loss documentation: Supplier letter, repair records, or a police report (for theft/loss) if applicable.
- Clinical change documentation: If the new request is for a different device type or pressure setting, include updated sleep study or titration results and a prescriber note explaining the clinical reason for the change.
- COB clarification: If dual coverage is involved, obtain a coordination-of-benefits determination letter showing which plan is primary.
- Prescriber medical-necessity letter: Confirms the current device is inadequate or absent and that the requested device is independently medically necessary.
## Criteria-Mapping Structure
For each criterion in UHC's CPAP/APAP coverage policy, cite the corresponding exhibit showing the current request is not a duplicate — either because the prior device is no longer available/functional, or because the clinical indication for the current request is distinct from any prior authorization. If the denial was a billing error, state that explicitly, attach the corrected claim, and request reprocessing alongside the appeal.
Next steps
- Find the date on the denial letter — your appeal window starts there.
- Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
- Request the insurer's claim file in writing — they must provide it.
- Submit your appeal in writing with new clinical evidence and a physician statement.
Get the letter drafted
DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.
Start my appeal — $30 with code SEO25 →Related appeal guides
- UnitedHealthcare denied as duplicate or overlapping therapy of ABA Autism
- UnitedHealthcare denied as duplicate or overlapping therapy of Amphetamine Stimulant
- UnitedHealthcare denied as duplicate or overlapping therapy of Amphetamine Stimulant Prodrug
- UnitedHealthcare denied as duplicate or overlapping therapy of Anti Amyloid Leqembi